NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 47, 2010, Pages 20477-20482

  Moon, Eui Jung ^a   Sonveaux, Pierre ^b   Porporato, Paolo E ^a   Danhier, Pierre ^b   Gallez, Bernard ^b   Batinic Haberle, Ines ^a   Nien, Yu Chih ^a   Schroeder, Thies ^a   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DNA FLANKING REGION; HYPERTHERMIC THERAPY; HYPOXIA; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REOXYGENATION; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR VASCULARIZATION; UPREGULATION;

EID: 78650580513     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006646107     Document Type: Article

References (55)

1. Song CW, Park H, Griffin RJ (2001) Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 155:515-528.
2. Vujaskovic Z, Song CW (2004) Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia 20:163-174.
3. Oleson JR (1995) Eugene Robertson Special Lecture. Hyperthermia from the clinic to the laboratory: A hypothesis. Int J Hyperthermia 11:315-322.
4. Brizel DM, et al. (1996) Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 56:5347-5350.
5. Vujaskovic Z, et al. (2003) Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia 19:498-506.
6. Jones EL, et al. (2004) Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 10:4287-4293.
7. Jones EL, et al. (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079-3085.
8. Hauck ML, et al. (2006) Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 12:4004-4010.
9. Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW (2006) Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22:205-213.
10. Ponce AM, et al. (2007) Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst 99: 53-63.
11. Shakil A, Osborn JL, Song CW (1999) Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Int J Radiat Oncol Biol Phys 43: 859-865.
12. Tamulevicius P, Luscher G, Streffer C (1987) Effects on intermediary metabolism in mouse tissues by Ro-03-8799. Br J Cancer 56:315-320.
13. Kelleher DK, Engel T, Vaupel PW (1995) Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon waterfiltered IR-A hyperthermia. Int J Hyperthermia 11:241-255.
14. Streffer C (1985) Metabolic changes during and after hyperthermia. Int J Hyperthermia 1:305-319.
15. Vaupel PW, Kelleher DK (2010) Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int J Hyperthermia 26:211-223.
16. Covello KL, Simon MC (2004) HIFs, hypoxia, and vascular development. Curr Top Dev Biol 62:37-54.
17. Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678-685.
18. Semenza GL (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19:12-16.
19. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
20. Moon EJ, Brizel DM, Chi JT, Dewhirst MW (2007) The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 9: 1237-1294.
21. Semenza GL (2009) Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 114:2015-2019.
22. Berra E, et al. (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22:4082-4090.
23. Forsythe JA, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
24. Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177-185.
25. Jackson IL, Batinic-Haberle I, Sonveaux P, Dewhirst MW, Vujaskovic Z (2006) ROS production and angiogenic regulation by macrophages in response to heat therapy. Int J Hyperthermia 22:263-273.
26. Katschinski DM, et al. (2002) Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J Biol Chem 277:9262-9267.
27. Wartenberg M, et al. (2005) Regulation of the multidrug resistance transporter Pglycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer 113:229-240. (Pubitemid 39628313)
28. Ferrara N (2004) Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25:581-611. (Pubitemid 39099316)
29. Li F, et al. (2007) Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 26:63-74.
30. Koch CJ (2002) Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol 352:3-31.
31. Cao Y, et al. (2005) Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res 65:5498-5505.
32. Jordan BF, et al. (2003) Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. Int J Radiat Oncol Biol Phys 55:1066-1073.
33. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basichelix- loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514.
34. Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5:429-441.
35. Batinic-Haberle I, Rebouças JS, Spasojevic I (2010) Superoxide dismutase mimics: Chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 13: 877-918.
36. Mansfield KD, et al. (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1:393-399.
37. Goyal P, et al. (2004) Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxiainducible factor 1 via increase in reactive oxygen species. Free Radic Biol Med 36: 1279-1288.
38. Choi JA, et al. (2010) Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway. Carcinogenesis 31:543-551.
39. Segal AW, Abo A (1993) The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 18:43-47.
40. Adachi Y, et al. (2008) Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6. Oncogene 27:4921-4932.
41. Han SI, et al. (2002) Mild heat shock induces cyclin D1 synthesis through multiple Ras signal pathways. FEBS Lett 515:141-145.
42. Shin MH, et al. (2008) Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression. Free Radic Biol Med 44:635-645.
43. Favata MF, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
44. Cairns RA, Papandreou I, Sutphin PD, Denko NC (2007) Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy. Proc Natl Acad Sci USA 104:9445-9450.
45. Wigfield SM, et al. (2008) PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer 98: 1975-1984.
46. Batinic-Haberle I, Liochev SI, Spasojevic I, Fridovich I (1997) A potent superoxide dismutase mimic: Manganese beta-octabromo-meso-tetrakis-(N- methylpyridinium-4- yl) porphyrin. Arch Biochem Biophys 343:225-233.
47. Bristow RG, Hill RP (2008) Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8:180-192.
48. Harada H, et al. (2007) Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene 26:7508-7516.
49. Song X, et al. (2006) Hypoxia-induced resistance to cisplatin and doxorubicin in nonsmall cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 58:776-784.
50. Brown LM, et al. (2006) Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol Pharmacol 69:411-418.
51. Sullivan R, Paré GC, Frederiksen LJ, Semenza GL, Graham CH (2008) Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol Cancer Ther 7:1961-1973.
52. Liu L, et al. (2008) Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99:121-128.
53. Yuan H, et al. (2006) Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 47: 989-998.
54. Rabbani ZN, et al. (2009) Antiangiogenic action of redox-modulating Mn(III) mesotetrakis( N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor. Free Radic Biol Med 47:992-1004.
55. Schroeder T, et al. (2005) Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res 65: 5163-5171.